Breast Implant ALCL Lawsuits Continue To Mount As New Cases of Cancer Diagnosed

A steady stream of new breast implant lawsuits continue to be filed against Allergan more than two years after a recall was issued for Biocell textured implants, as women continue to be diagnosed with new cases of a rare cancer linked to the design, which is now commonly referred to as breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).

Allergan Biocell implants were sold for years, featuring a macrotextured surface that has now be linked to an increased risk of cancer that may develop in the tissue surrounding the implant. A massive breast implant recall was issued in July 2019, removing the entire product line from the global market due to concerns about long-term cancer risks as the textured implants remained in place.

Nearly 1,000 product liability lawsuits have been filed by women throughout the federal court system over the past two years, which were consolidated before one federal judge in December 2019, as part of a multidistrict litigation, or MDL. However, new complaints continue to be brought, often involving women diagnosed with the breast implant lymphoma years after the recall.

Last month, a complaint (PDF) was filed by Janet Nolan, indicating that she was diagnosed with breast implant ALCL in September 2021, alleging that the cancer was caused by one of Allergan’s Natrelle saline-filled breast implants placed in June 2004.

Similarly, another complaint (PDF) was filed on Monday by Meagan Joplin, of Texas, indicating that she was diagnosed with BIA-ALCL in July 2021, after receiving defective implants in May 2016. As a result of the recent cancer diagnosis, the breast implants were explanted in August 2021.

While the size and scope of the breast implant litigation continues to grow, coordinated discovery is being conducted by the parties and a small group of bellwether claims are being prepared for early trial dates to help the parties gauge how juries may respond to certain evidence and testimony that will be repeated throughout the lawsuits.

Irvin Jackson
Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A public health advocacy group and two Pennsylvania men have filed a lawsuit against FanDuel, DraftKings and the NFL over the use of data for addictive, live in-game microbets.
Insulet is removing certain Omnipod 5 insulin pump pods from use following a surge in reports of insulin delivery failures that raise risks of diabetic ketoacidosis and other serious complications.
A Florida womanโ€™s lawsuit alleges that Abbott Laboratories and Boston Scientific altered their SCS device batteries, firmware and stimulation features without adequate safety testing approved by the FDA.